Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03380130 |
|---|---|
| Brief Title: | A Study of the Safety and Antitumoral Efficacy of Nivolumab After SIRT for the Treatment of Patients With HCC (NASIR-HCC) |
| First Submitted : | October 20, 2017 |
| First Submitted that Met QC Criteria : | December 19, 2017 |
| First Posted : | December 20, 2017 |
| Last Update Submitted that Met QC Criteria : | November 3, 2020 |
| Last Update Posted : | November 4, 2020 |